Cargando…

Efficacy of diet restriction with or without probiotic for treatment of patients with IBS‐D: Phase I−II clinical trial

BACKGROUND AND AIM: Diet is a major contributor to irritable bowel syndrome (IBS) and is also a powerful tool for treatment of IBS. This study compared two diets and explored the effectiveness of the diets when combined with a probiotic for treatment of IBS‐D patients. METHODS: Phase I, patients wer...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Xian‐Shu, Shi, Li‐Jun, Ning, Bao‐Li, Zhao, Zhi‐Ming, Li, Xiao‐Xue, Zhu, Meng‐Hua, Zhang, Ya‐Bing, Fu, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10165954/
https://www.ncbi.nlm.nih.gov/pubmed/37249280
http://dx.doi.org/10.1002/iid3.857
_version_ 1785038346727194624
author Zhao, Xian‐Shu
Shi, Li‐Jun
Ning, Bao‐Li
Zhao, Zhi‐Ming
Li, Xiao‐Xue
Zhu, Meng‐Hua
Zhang, Ya‐Bing
Fu, Jun
author_facet Zhao, Xian‐Shu
Shi, Li‐Jun
Ning, Bao‐Li
Zhao, Zhi‐Ming
Li, Xiao‐Xue
Zhu, Meng‐Hua
Zhang, Ya‐Bing
Fu, Jun
author_sort Zhao, Xian‐Shu
collection PubMed
description BACKGROUND AND AIM: Diet is a major contributor to irritable bowel syndrome (IBS) and is also a powerful tool for treatment of IBS. This study compared two diets and explored the effectiveness of the diets when combined with a probiotic for treatment of IBS‐D patients. METHODS: Phase I, patients were randomized into groups; control, cold/spicy/fried restricted diet (CSF res diet), IgG positive restricted diet (IgG res diet), and a combination both diets (CSF + IgG res diet). Phase II, patients were randomized into IgG res diet + placebo and IgG res diet + probiotic. Both interventions were 12 weeks in duration. Symptom Severity Scale (IBS‐D‐SSS) and IgG titer were assessed at the beginning and the end of the study. RESULTS: Totals of 214 and 167 patients completed the two parts of the study, respectively. After intervention, IBS‐D‐SSS and TIgG grade were significantly improved compared to baseline, with results similar to the control group. In general, there were decreases in IBS‐D‐SSS and TIgG grade that were significantly different among the groups. There were exceptions; no differences were observed for IBS‐D‐SSS between the IgG res diet and CSF + IgG res diet, or TIgG grade between the CSF res diet, IgG res diet, and CSF + IgG res diet. However, the CSF res diet and IgG res diet had a synergistic effect that decreased IBS‐D‐SSS and TIgG titer, with a greater contribution by the IgG res diet. Therefore, we evaluated the IgG res diet with either placebo or probiotic and found that IBS‐D‐SSS and TIgG grade decreased from baseline. There was a significant decrease in IBS‐D‐SSS with the probiotic but TIgG grade was not significantly different between the IgG diet + placebo and IgG diet + probiotic diet. CONCLUSIONS: Both the CSF res diet and IgG res diet improved IBS symptoms and demonstrated synergy, although the IgG res diet had a greater contribution. Further, when intolerant foods cannot be eliminated from a diet, avoiding uncooked, cold, spicy, fried, and alcoholic foods is a superior choice. The IgG res diet combined with Bifidobacteria was the best dietary choice and may function though a non‐IgG pathway.
format Online
Article
Text
id pubmed-10165954
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-101659542023-05-09 Efficacy of diet restriction with or without probiotic for treatment of patients with IBS‐D: Phase I−II clinical trial Zhao, Xian‐Shu Shi, Li‐Jun Ning, Bao‐Li Zhao, Zhi‐Ming Li, Xiao‐Xue Zhu, Meng‐Hua Zhang, Ya‐Bing Fu, Jun Immun Inflamm Dis Original Articles BACKGROUND AND AIM: Diet is a major contributor to irritable bowel syndrome (IBS) and is also a powerful tool for treatment of IBS. This study compared two diets and explored the effectiveness of the diets when combined with a probiotic for treatment of IBS‐D patients. METHODS: Phase I, patients were randomized into groups; control, cold/spicy/fried restricted diet (CSF res diet), IgG positive restricted diet (IgG res diet), and a combination both diets (CSF + IgG res diet). Phase II, patients were randomized into IgG res diet + placebo and IgG res diet + probiotic. Both interventions were 12 weeks in duration. Symptom Severity Scale (IBS‐D‐SSS) and IgG titer were assessed at the beginning and the end of the study. RESULTS: Totals of 214 and 167 patients completed the two parts of the study, respectively. After intervention, IBS‐D‐SSS and TIgG grade were significantly improved compared to baseline, with results similar to the control group. In general, there were decreases in IBS‐D‐SSS and TIgG grade that were significantly different among the groups. There were exceptions; no differences were observed for IBS‐D‐SSS between the IgG res diet and CSF + IgG res diet, or TIgG grade between the CSF res diet, IgG res diet, and CSF + IgG res diet. However, the CSF res diet and IgG res diet had a synergistic effect that decreased IBS‐D‐SSS and TIgG titer, with a greater contribution by the IgG res diet. Therefore, we evaluated the IgG res diet with either placebo or probiotic and found that IBS‐D‐SSS and TIgG grade decreased from baseline. There was a significant decrease in IBS‐D‐SSS with the probiotic but TIgG grade was not significantly different between the IgG diet + placebo and IgG diet + probiotic diet. CONCLUSIONS: Both the CSF res diet and IgG res diet improved IBS symptoms and demonstrated synergy, although the IgG res diet had a greater contribution. Further, when intolerant foods cannot be eliminated from a diet, avoiding uncooked, cold, spicy, fried, and alcoholic foods is a superior choice. The IgG res diet combined with Bifidobacteria was the best dietary choice and may function though a non‐IgG pathway. John Wiley and Sons Inc. 2023-05-08 /pmc/articles/PMC10165954/ /pubmed/37249280 http://dx.doi.org/10.1002/iid3.857 Text en © 2023 The Authors. Immunity, Inflammation and Disease published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Zhao, Xian‐Shu
Shi, Li‐Jun
Ning, Bao‐Li
Zhao, Zhi‐Ming
Li, Xiao‐Xue
Zhu, Meng‐Hua
Zhang, Ya‐Bing
Fu, Jun
Efficacy of diet restriction with or without probiotic for treatment of patients with IBS‐D: Phase I−II clinical trial
title Efficacy of diet restriction with or without probiotic for treatment of patients with IBS‐D: Phase I−II clinical trial
title_full Efficacy of diet restriction with or without probiotic for treatment of patients with IBS‐D: Phase I−II clinical trial
title_fullStr Efficacy of diet restriction with or without probiotic for treatment of patients with IBS‐D: Phase I−II clinical trial
title_full_unstemmed Efficacy of diet restriction with or without probiotic for treatment of patients with IBS‐D: Phase I−II clinical trial
title_short Efficacy of diet restriction with or without probiotic for treatment of patients with IBS‐D: Phase I−II clinical trial
title_sort efficacy of diet restriction with or without probiotic for treatment of patients with ibs‐d: phase i−ii clinical trial
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10165954/
https://www.ncbi.nlm.nih.gov/pubmed/37249280
http://dx.doi.org/10.1002/iid3.857
work_keys_str_mv AT zhaoxianshu efficacyofdietrestrictionwithorwithoutprobioticfortreatmentofpatientswithibsdphaseiiiclinicaltrial
AT shilijun efficacyofdietrestrictionwithorwithoutprobioticfortreatmentofpatientswithibsdphaseiiiclinicaltrial
AT ningbaoli efficacyofdietrestrictionwithorwithoutprobioticfortreatmentofpatientswithibsdphaseiiiclinicaltrial
AT zhaozhiming efficacyofdietrestrictionwithorwithoutprobioticfortreatmentofpatientswithibsdphaseiiiclinicaltrial
AT lixiaoxue efficacyofdietrestrictionwithorwithoutprobioticfortreatmentofpatientswithibsdphaseiiiclinicaltrial
AT zhumenghua efficacyofdietrestrictionwithorwithoutprobioticfortreatmentofpatientswithibsdphaseiiiclinicaltrial
AT zhangyabing efficacyofdietrestrictionwithorwithoutprobioticfortreatmentofpatientswithibsdphaseiiiclinicaltrial
AT fujun efficacyofdietrestrictionwithorwithoutprobioticfortreatmentofpatientswithibsdphaseiiiclinicaltrial